Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2024-09-11 00:00:00 ET · period of report 2024-09-09 · accession 0001104659-24-098941 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-11 | 2024-09-09 | RYTM | GOOD JENNIFER L | Dir | M - OptEx | $13.34 | +37.2K | 40.2K | +1,241% | +$496.7K |
| D | 2024-09-11 | 2024-09-09 | RYTM | GOOD JENNIFER L | Dir | S - Sale+OE | $50.45 | -37.2K | 3,000 | -93% | -$1.88M |
| DM | 2024-09-11 | 2024-09-09 | RYTM | GOOD JENNIFER L | Dir | M - OptEx | $0.00 | -37.2K | 15.0K | -71% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-09 | M | A | 1,736 | $18.99 | 21,941 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-09 | M | A | 4,305 | $21.37 | 20,205 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-09 | M | A | 12,900 | $22.93 | 15,900 | D | — | — | |
| 4 | Common | Common Stock | 2024-09-09 | S | D | 37,241 | $50.45 | 3,000 | D | — | — | (F2) The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $50.00 to $50.99. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2024-09-09 | M | A | 18,300 | $4.15 | 40,241 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2024-09-09 | M | D | 18,300 | $0.00 | 0 | D | $4.15 · — to 2032-06-07 | 18,300 Common Stock | (F3) The option is fully vested and exercisable. |
| 7 | Derivative | Stock Option (right to buy) | 2024-09-09 | M | D | 4,305 | $0.00 | 9,250 | D | $21.37 · — to 2030-06-16 | 4,305 Common Stock | (F3) The option is fully vested and exercisable. |
| 8 | Derivative | Stock Option (right to buy) | 2024-09-09 | M | D | 1,736 | $0.00 | 7,501 | D | $18.99 · — to 2031-06-08 | 1,736 Common Stock | (F3) The option is fully vested and exercisable. |
| 9 | Derivative | Stock Option (right to buy) | 2024-09-09 | M | D | 12,900 | $0.00 | 15,000 | D | $22.93 · — to 2029-06-18 | 12,900 Common Stock | (F3) The option is fully vested and exercisable. |